{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:35:44Z","timestamp":1768250144838,"version":"3.49.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T00:00:00Z","timestamp":1317168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with \u03b2-thalassemia major require iron-chelation therapy to avoid the complication of iron overload. Until recently, deferoxamine (DFO) was the major iron chelator used in patients requiring chronic hypertransfusion therapy, but DFO required continuous subcutaneous therapy. The availability of deferasirox (Exjade\u00ae), an orally active iron chelator, over the past 4 years represented a necessary alternative for patients requiring chelation therapy. However, there have been increasing reports of proximal renal tubular dysfunction and Fanconi Syndrome associated with deferasirox in the literature. We report a case of hypophosphataemic osteomalacia secondary to deferasirox therapy. \u00a9 2012 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.522","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T14:41:47Z","timestamp":1317220907000},"page":"219-222","source":"Crossref","is-referenced-by-count":19,"title":["A case of hypophosphatemic osteomalacia secondary to deferasirox therapy"],"prefix":"10.1093","volume":"27","author":[{"given":"Frances","family":"Milat","sequence":"first","affiliation":[{"name":"Monash University Department of Medicine, Melbourne, Australia"},{"name":"Prince Henry's Institute and Department of Endocrinology, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Wong","sequence":"additional","affiliation":[{"name":"Monash University Department of Medicine, Melbourne, Australia"},{"name":"Prince Henry's Institute and Department of Endocrinology, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J","family":"Fuller","sequence":"additional","affiliation":[{"name":"Monash University Department of Medicine, Melbourne, Australia"},{"name":"Prince Henry's Institute and Department of Endocrinology, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Johnstone","sequence":"additional","affiliation":[{"name":"Paediatric Renal Department, Monash Children's, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G","family":"Kerr","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia"},{"name":"Monash University Department of Medicine, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James CG","family":"Doery","sequence":"additional","affiliation":[{"name":"Department of Pathology, Monash Medical Centre, Clayton, Victoria, Australia"},{"name":"Monash University Department of Medicine, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyd J","family":"Strauss","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Monash Medical Centre, Clayton, Victoria, Australia"},{"name":"Monash University Department of Medicine, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald K","family":"Bowden","sequence":"additional","affiliation":[{"name":"Thalassemia Service, Monash Medical Centre, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,9,28]]},"reference":[{"key":"2024020318093746100_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MPH.0b013e3181ec0c4d","article-title":"Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire","volume":"32","author":"Baum","year":"2010","journal-title":"J Pediatr Hematol Oncol."},{"key":"2024020318093746100_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.21588","article-title":"Deferasirox treatment may be associated with reversible renal Fanconi syndrome","volume":"85","author":"Even-Or","year":"2010","journal-title":"Am J Hematol."},{"key":"2024020318093746100_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.ajkd.2009.03.013","article-title":"Fanconi syndrome due to deferasirox","volume":"54","author":"Rafat","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"2024020318093746100_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/MPH.0b013e3181ec0c38","article-title":"Acquired proximal renal tubular dysfunction in \u03b2-thalassemia patients treated with deferasirox","volume":"32","author":"Yacobovich","year":"2010","journal-title":"J Pediatr Hematol Oncol."},{"key":"2024020318093746100_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMct1004810","article-title":"Iron-chelating therapy for transfusional iron overload","volume":"364","author":"Brittenham","year":"2011","journal-title":"N Engl J Med."},{"key":"2024020318093746100_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00467-008-0753-x","article-title":"Early markers of renal dysfunction in patients with beta-thalassemia major","volume":"23","author":"Mohkam","year":"2008","journal-title":"Pediatr Nephrol."},{"key":"2024020318093746100_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.blre.2010.08.004","article-title":"Renal complications in transfusion-dependent beta thalassaemia","volume":"24","author":"Ponticelli","year":"2010","journal-title":"Blood Rev."},{"key":"2024020318093746100_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000287238","article-title":"Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox","volume":"123","author":"Economou","year":"2010","journal-title":"Acta Haematol."},{"key":"2024020318093746100_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s004670050453","article-title":"Renal tubular function in \u03b2-thalassemia","volume":"12","author":"Sumboonnanonda","year":"1998","journal-title":"Pediatr Nephrol."},{"key":"2024020318093746100_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1824-7288-36-39","article-title":"Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study","volume":"36","author":"Hamed","year":"2010","journal-title":"Ital J Pediatr."},{"key":"2024020318093746100_bib11","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00467-008-0897-8","article-title":"Renal function in children with \u03b2-thalassemia major and thalassemia intermedia","volume":"23","author":"Smolkin","year":"2008","journal-title":"Pediatr Nephrol."},{"key":"2024020318093746100_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004670000434","article-title":"Renal function in pediatric patients with \u03b2-thalassemia major","volume":"15","author":"Aldudak","year":"2000","journal-title":"Pediatr Nephrol."},{"key":"2024020318093746100_bib13","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","article-title":"Aphase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with \u03b2-thalassemia","volume":"107","author":"Cappellini","year":"2006","journal-title":"Blood."},{"key":"2024020318093746100_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1440-1797.2009.01183.x","article-title":"Acute interstitial nephritis secondary to deferasirox causing acute renal injury needing short-term dialysis","volume":"15","author":"Yew","year":"2010","journal-title":"Nephrology."},{"key":"2024020318093746100_bib15","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study","volume":"94","author":"Schouten","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318093746100_bib16","first-page":"1529","article-title":"Rickets\/osteomalacia due to tubular dysfunction","volume":"17","author":"Sekine","year":"2007","journal-title":"Clin Calcium."},{"key":"2024020318093746100_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00774-009-0079-1","article-title":"Hypophosphatemia: the common denominator of all rickets","volume":"27","author":"Tiosano","year":"2009","journal-title":"J Bone Min Metab."},{"key":"2024020318093746100_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1995.tb02621.x","article-title":"Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features","volume":"43","author":"Clarke","year":"1995","journal-title":"Clin Endocrinol."},{"key":"2024020318093746100_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jocd.2005.11.001","article-title":"Changes in bone mineral density following treatment of osteomalacia","volume":"9","author":"Bhambri","year":"2006","journal-title":"J Clin Densitom."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.522","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/1\/219\/56561649\/522_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/1\/219\/56561649\/522_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:48:13Z","timestamp":1710341293000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/27\/1\/219-222\/7598444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,28]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,9,28]]},"published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.522","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,1,1]]},"published":{"date-parts":[[2011,9,28]]}}}